Company / Inventory
AXIM BIOTECHNOLOGIES, INC. Inventory History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$9.8K
FY2018
5-year range
$8.8K / $38.4K
FY2015-FY2018
Trend
+11.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2018 after 2 years of decline, reaching $9,797.
Based on SEC 10-K filings.
$9,797 in FY2018 with a 3-year CAGR of -63.5%.
Declined from $38,446 to $9,797 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -63.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -63.5%, indicating a declining trend.
- In FY2018, inventory increased 11.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2018 | $9.8K | +11.8% |
| FY2017 | $8.8K | -77.2% |
| FY2016 | $38.4K | -80.9% |
| FY2015 | $200.8K | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2018 · SEC 10-K · Updated Jun 29, 2026